ChartMill assigns a Buy % Consensus number of 78% to ICVX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-01-02 | Guggenheim | Downgrade | Buy -> Neutral |
| 2023-11-17 | Guggenheim | Initiate | Buy |
| 2023-10-02 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-04-25 | Oppenheimer | Reiterate | Outperform |
| 2023-01-04 | Oppenheimer | Initiate | Outperform |
| 2021-08-23 | William Blair | Initiate | Outperform |
| 2021-08-23 | Cowen & Co. | Initiate | Outperform |
| 2021-08-23 | Evercore ISI Group | Initiate | Outperform |
| 2021-08-23 | Jefferies | Initiate | Buy |
12 analysts have analysed ICVX and the average price target is 18.87 USD. This implies a price increase of 23.25% is expected in the next year compared to the current price of 15.31.
The consensus rating for ICOSAVAX INC (ICVX) is 78.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering ICOSAVAX INC (ICVX) is 12.